Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling-Reference-Cited by-同舟云学术

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

Published:2017-06-27 Issue:17 Volume:77 Page:4562-4566
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Donia Marco,Harbst Katja,van Buuren Marit,Kvistborg Pia,Lindberg Mattias F.,Andersen Rikke,Idorn Manja,Munir Ahmad Shamaila,Ellebæk Eva,Mueller Anja,Fagone Paolo,Nicoletti Ferdinando,Libra Massimo,Lauss Martin,Hadrup Sine Reker,Schmidt Henrik,Andersen Mads Hald,thor Straten Per,Nilsson Jonas A.,Schumacher Ton N.,Seliger Barbara,Jönsson Göran,Svane Inge Marie

Funder

Danish Cancer Society

German Cancer Aid

Italian Foundation for Cancer Research

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes;Cancer Immunology Research;2024-04-17

2. Rewiring chaperone-mediated autophagy in cancer by a prion-like chemical inducer of proximity to counteract adaptive immune resistance;Drug Resistance Updates;2024-03

3. Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma;Journal of Translational Medicine;2023-09-20

4. Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy;Cell;2023-08

5. Identification of distinct tumor cell patterns with single-cell RNA sequencing integrating primary lung adenocarcinoma and brain metastasis tumor;Translational Lung Cancer Research;2023-03